July 15, 2020
Astellas Pharma said on July 14 that it will transfer the marketing authorization and distribution rights for its antipsychotic Dogmatyl (sulpiride) to generic major Nichi-Iko Pharmaceutical, effective October 1. Subject to the transfer are Dogmatyl Tablets 50 mg/100 mg/200 mg,...read more